Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2015 | Current clinical perspectives on targeted therapy and immunotherapy for melanoma

Caroline Robert • 30 May 2015
ASCO 2015
Skin Cancer

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Caroline Robert, MD, PhD, from Institut Gustave Roussy, Villejuif, France, considers the impact of available and emerging targeted therapies and immunotherapies on the current treatment landscape in melanoma.

More from Caroline Robert

1:26
Metastatic melanoma: the CheckMate 067 and 069 trials
Caroline Robert • 8 Sep 2017
1:41
How can patients undergoing immunotherapy be supported?
Caroline Robert • 8 Sep 2017
2:21
When should treatment be stopped?
Caroline Robert • 8 Sep 2017
5:40
Immunotherapy and targeted therapies for melanoma
Caroline Robert • 30 May 2015

Related Videos

2:15
Reducing the need for sentinel node biopsies in cutaneous melanoma
Christoffer Gebhardt • 9 Apr 2024
1:20
Can ctDNA guide the treatment decision making process in melanoma?
Christoffer Gebhardt • 9 Apr 2024
1:18
Elucidating ICI resistance in melanoma with ctDNA and tumor profiling
Christoffer Gebhardt • 9 Apr 2024
1:48
Ultra-sensitive ctDNA monitoring predicts ICI response in melanoma
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals